Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1322326 | 0.83 | — | — | |
| SCHEMBL2133082 | 0.82 | ALDH1A1 (0.38) | KDM4EALDH1A1TDP1MMP9 | |
| SCHEMBL6117737 | 0.80 | KDM4E (0.36) | KDM4EALDH1A1TDP1 | |
| SCHEMBL20896993 | 0.79 | TDP1 (0.31) | ALDH1A1TDP1 | |
| SCHEMBL28446583 | 0.76 | MGLL (0.33) | KDM4EALDH1A1TDP1 | |
| SCHEMBL1322330 | 0.75 | MGLL (0.32) | — | |
| SCHEMBL16820490 | 0.75 | TDP1 (0.32) | KDM4EALDH1A1TDP1 | |
| SCHEMBL668332 | 0.75 | RECQL (0.37) | KDM4EALDH1A1LMNA | |
| SCHEMBL26827993 | 0.75 | ALDH1A1 (0.34) | KDM4EALDH1A1TDP1LMNA | |
| SCHEMBL2131788 | 0.74 | ALDH1A1 (0.46) | KDM4EALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11163232-B2 | Resist composition, patterning process, and barium salt | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-11-02 | — | — | US | disclosed |
| US-20190113846-A1 | RESIST COMPOSITION, PATTERNING PROCESS, AND BARIUM SALT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11163232-B2 | Resist composition, patterning process, and barium salt | LBR, SMARCC2, SMARCC1 | KDM4E 2771/4885ALDH1A1 4751/4885TDP1 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.